Executive dysfunction in major depressive disorder

Expert Review of Neurotherapeutics

Volumn 5, Issue 1, 2005, Pages 79-83

  DeBattista, Charles ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dysfunction; Executive; Major depressive disorder

Indexed keywords

DOPAMINE; FLUOXETINE; HISTAMINE; MODAFINIL; NORADRENALIN;

ATTENTION DEFICIT DISORDER; DOPAMINE RELEASE; GERIATRIC PATIENT; HISTAMINE RELEASE; HUMAN; MAJOR DEPRESSION; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NORADRENALIN RELEASE; PSYCHOLOGIC ASSESSMENT; RELAPSE; REVIEW; WORKING MEMORY;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; EXPERT TESTIMONY; HUMANS; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING;

EID: 12344258720     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.5.1.79     Document Type: Review

References (36)

1. APA. Diagnostic and Statistical Manual of Mental Disorders IV. Fourth Edition. American Psychiatric Press, Washington DC, USA (1994).
2. Elliott R. Executive functions and their disorders. Br. Med. Bull. 65, 49-59 (2003).
3. Ravnkilde B, Videbech P, Clemmensen K, Egander A, Rasmussen NA, Rosenberg R. Cognitive deficits in major depression. Scand. J. Psych. 43(3), 239-251 (2002).
4. Moritz S, Birkner C, Kloss M et al. Impact of comorbid depressive symptoms on neuropsychological performance in obsessive-compulsive disorder. J. Ab. Psychology 110(4), 653-657 (2001).
5. Trichard C, Martinot JL, Alagille M et al. Time course of prefrontal lobe dysfunction in severely depressed inpatients: a longitudinal neuropsychological study. Psychol. Med. 25(1), 79-85 (1995).
6. Elliott R, Baker SC, Rogers RD et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol. Med. 27(4), 931-942 (1997).
7. Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological function in young patients with unipolar major depression. Psychol. Med. 27(6), 1277-1285 (1997).
8. Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: a review. Encephale 28(2), 97-107 (2002).
9. Channon S, Green PS. Executive function in depression: the role of performance strategies in aiding depressed and non-depressed participants. J. Neurol. Neurosurg. Psych. 66(2), 162-171 (1999).
10. Austin MP, Mitchell P, Wilhelm K et al. Cognitive function in depression: a distinct pattern of frontal impairment in melancholia? Psychol. Med. 29(1), 73-85 (1999).
11. Degl'Innocenti A, Agren H, Backman L. Executive deficits in major depression. Acta Psych. Scand. 97(3), 182-188 (1998).
12. Elliott R, McKenna PJ, Robbins TW, Sahakian BJ. Neuropsychological evidence for frontostriatal dysfunction in schizophrenia. Psych. Med. 25(3), 619-630 (1995).
13. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am. J. Psych. 156(5), 780-782 (1999).
14. Henriques JDR. Decreased responsiveness to reward in depression. Cog. Emotion 14(5), 711-742 (2000).
15. Kindermann SS, Kalayam B, Brown GG, Burdick KE, Alexopoulos GS. Executive functions and P300 latency in elderly depressed patients and control subjects. Am. J. Geriatric Psych. 8(1), 57-65 (2000).
16. Schatzberg A, Khalezhan M, Rothschild AJ. Neuropsychologica deficits in psychotic versus nonpsychotic major depression and no mental illness. Am. J. Psychiatry 157, 1095-1100 (2000).
17. Hill SK, Keshavan MS, Thase ME, Sweeney JA. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am. J. Psych. 161(6), 996-1003 (2003).
18. Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am. J. Psychiatry 149(6), 733-745 (1992).
19. Tohen M, Stoll AL, Strakowski SM et al. The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schiz. Bull. 18(2), 273-282 (1992).
20. Kiosses DN, Alexopoulos GS, Murphy C. Symptoms of striatofrontal dysfunction contribute to disability in geriatric depression. Int. J. Geriatric Psych. 15(11), 992-999 (2000).
21. Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am. J. Psychiatry 159(7), 1119-1126 (2003).
22. Alexopoulos GS, Meyers BS, Young RC et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch. Gen. Psych. 57(3), 285-290 (2000).
23. Dunkin JJ, Leuchter AF, Cook IA et al. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J. Affect. Dis. 60(1), 13-23 (2000). One of the first studies to document the realtionship of executive functioning to treatment response in major depression.
24. Kalayam BAG. Prefrontal dsyfunction and treatment response in geriatric depression. Arch. Gen. Psych. 56, 713-718 (1999).
25. Stahl S. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J. Clin. Psychiatry 64(Suppl. 14), 6-17. Good overview of the current thinking of the neurobiologic basis of executive dysfunction and its potential pharmacotherapy.
26. Batejat DM, Lagarde DP. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviation Space Environmental Med. 70(5), 493-498 (1999).
27. Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29(7), 1363-1373 (2004).
28. Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatric Neurol. 29(2), 136-142 (2003).
29. Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J. Child Adolesc. Psychopharmacol. 10(4), 311-320 (2000).
30. Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. Clin. Neuropharmacol. 27(2), 74-79 (2004).
31. DeBattista C, Lembke A, Solvason HB, Ghebremichael R, Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. J. Clin. Psychopharmacol. 24(1), 87-90 (2004).
32. Magill R. Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nut. Neurosci. 6(4), 237-246 (2003).
33. Vance AL, Maruff P, Barnett R. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication. Aus. NZ J. Psych. 37(5), 570-576 (2003).
34. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psych. Med. 29(3), 527-538 (1999).
35. Spencer T, Biederman J, Heiligenstein J et al. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 11(3), 251-265 (2001).
36. Alexopoulos GS, Raue P, Arean P. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am. J. Geriatric Psych. 11(1), 46-52 (2003).